⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9626997 | 0.91 | — | — | |
| SCHEMBL13776530 | 0.82 | — | — | |
| SCHEMBL2512513 | 0.82 | — | — | |
| SCHEMBL1765713 | 0.80 | — | — | |
| SCHEMBL31281037 | 0.80 | — | — | |
| SCHEMBL27280308 | 0.78 | — | — | |
| SCHEMBL11300457 | 0.78 | — | — | |
| SCHEMBL15564587 | 0.78 | — | — | |
| SCHEMBL3746748 | 0.78 | — | — | |
| SCHEMBL31281825 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117584473-B | High-low temperature resistant flame-retardant composite board and preparation process thereof | 尤特森新材料集团有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117584473-A | High-low temperature resistant flame-retardant composite board and preparation process thereof | 尤特森新材料集团有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-116262709-A | Method for preparing amide by alcohol oxidation and cleavage | 中国科学院大连化学物理研究所 | 2023-06-16 | — | — | CN | disclosed |
| US-6646012-B2 | Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents | THERAVANCE, INC. | 2003-11-11 | — | — | US | disclosed |
| US-20030065013-A1 | Sodium channel modulators | THERAVANCE BIOPHARMA R&D IP, LLC | 2003-04-03 | — | — | US | disclosed |
| US-6133446-A | Heterocyclic compounds for the treatment of CNS and cardiovascular disorders | PHARMACIA & UPJOHN COMPANY (US) | 2000-10-17 | — | — | US | disclosed |